TissueLab’s mission is to produce synthetic tissues and organs for therapeutic applications.
TissueLabs has raised €739k across 1 funding round from 2 investors, most recently a Pre-Seed round in Mar 2024. Based in Manno, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-03-22 | Pre-Seed | €739k |
| Mergus Ventures,MIT Angels |
| View deal → |
